Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | CYSLTR1 | Q9Y271 | 4/20 | 0.47 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.47 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9766867 | 0.94 | CYSLTR1 (0.45) | CYSLTR1 | |
| SCHEMBL9760846 | 0.85 | ALOX5 (0.49) | ALOX5CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL9757258 | 0.82 | CYSLTR1 (0.60) | ALOX5CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL9757208 | 0.82 | CYSLTR1 (0.61) | ALOX5CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL9757426 | 0.79 | PDE10A (0.45) | ALOX5CYSLTR1 | |
| SCHEMBL8802120 | 0.76 | PDE10A (0.55) | ALOX5CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL8801668 | 0.75 | CYSLTR1 (0.62) | ALOX5CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL9756934 | 0.75 | CYSLTR1 (0.60) | ALOX5CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL7008285 | 0.75 | CYSLTR1 (0.60) | CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL9757134 | 0.74 | CYSLTR1 (0.58) | ALOX5CYSLTR1GPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1991019475-A2 | QUINOLINYL-BENZOHETEROBICYCLIC DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D¿4? | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1991-12-26 | — | — | WO | disclosed |
| US-5041453-A | Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-08-20 | — | — | US | disclosed |